Large-scale testing (Phase 3)UnknownNCT00002659
What this trial is testing
Cisplatin Plus Epinephrine in Treating Patients With Recurrent or Refractory Head and Neck Cancer
Who this might be right for
Head and Neck Cancer
Matrix Pharmaceutical 120
Showing 20 of 0 results